Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1971 2
1972 1
1973 1
1974 1
1975 2
1976 3
1977 2
1978 1
1979 1
1981 1
1982 2
1984 1
1985 5
1986 2
1987 8
1988 7
1989 6
1990 5
1991 9
1992 11
1993 8
1994 4
1995 6
1996 12
1997 11
1998 18
1999 21
2000 17
2001 16
2002 18
2003 19
2004 25
2005 14
2006 49
2007 47
2008 43
2009 27
2010 32
2011 45
2012 51
2013 72
2014 78
2015 93
2016 106
2017 99
2018 112
2019 118
2020 145
2021 179
2022 132
Text availability
Article attribute
Article type
Publication date

Search Results

1,559 results
Results by year
Filters applied: . Clear all
Page 1
FOXA1 overexpression suppresses interferon signaling and immune response in cancer.
He Y, Wang L, Wei T, Xiao YT, Sheng H, Su H, Hollern DP, Zhang X, Ma J, Wen S, Xie H, Yan Y, Pan Y, Hou X, Tang X, Suman VJ, Carter JM, Weinshilboum R, Wang L, Kalari KR, Weroha SJ, Bryce AH, Boughey JC, Dong H, Perou CM, Ye D, Goetz MP, Ren S, Huang H. He Y, et al. Among authors: sheng h. J Clin Invest. 2021 Jul 15;131(14):e147025. doi: 10.1172/JCI147025. J Clin Invest. 2021. PMID: 34101624 Free PMC article.
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer.
He Y, Wei T, Ye Z, Orme JJ, Lin D, Sheng H, Fazli L, Jeffrey Karnes R, Jimenez R, Wang L, Wang L, Gleave ME, Wang Y, Shi L, Huang H. He Y, et al. Among authors: sheng h. Nat Commun. 2021 Mar 9;12(1):1521. doi: 10.1038/s41467-021-21860-7. Nat Commun. 2021. PMID: 33750801 Free PMC article.
1,559 results